Ribociclib is a targeted therapy used in the treatment of breast cancer, particularly hormone receptor-positive, HER2-negative breast cancer. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which play a key role in cancer cell division. Ribociclib is used in combination with other treatments like aromatase inhibitors to prevent cancer cell growth.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Ribociclib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Ribociclib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Ribociclib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
